Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. | Director | Common Stock | 18.2K | $2.29M | $126.19 | Mar 1, 2024 | Direct |
CASSAVA SCIENCES INC | Director | Stock Option (Right to Buy) | 10K | $169K | $16.87 | May 9, 2024 | Direct |
Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | Jun 24, 2024 | Direct | ||
Chemomab Therapeutics Ltd. | Director | Option to Purchase American Depositary Shares | 11.9K | Mar 16, 2023 | Direct | ||
Sarepta Therapeutics, Inc. | Director | Stock Option (right to buy) | 3.68K | Mar 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GANX | Gain Therapeutics, Inc. | Jun 24, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
SAVA | CASSAVA SCIENCES INC | May 9, 2024 | 1 | $0 | 4 | May 13, 2024 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Director |
SAVA | CASSAVA SCIENCES INC | Dec 6, 2023 | 1 | $0 | 4 | Dec 8, 2023 | Director |
SAVA | CASSAVA SCIENCES INC | Dec 6, 2023 | 0 | $0 | 3 | Dec 8, 2023 | Director |
GANX | Gain Therapeutics, Inc. | Jun 23, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
CMMB | Chemomab Therapeutics Ltd. | Mar 16, 2023 | 3 | $0 | 4 | Mar 23, 2023 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 6, 2023 | 2 | $0 | 4 | Mar 8, 2023 | Director |
GANX | Gain Therapeutics, Inc. | Sep 20, 2022 | 1 | $0 | 4 | Sep 22, 2022 | Director |
CMMB | Chemomab Therapeutics Ltd. | Mar 7, 2022 | 2 | $0 | 4 | Mar 9, 2022 | Director |
SRPT | Sarepta Therapeutics, Inc. | Mar 7, 2022 | 2 | $0 | 4 | Mar 8, 2022 | Director |